Developmental Regression and Mitochondrial Dysfunction in a Child With Autism

Abstract

Autistic spectrum disorders can be associated with mitochondrial dysfunction. We present a singleton case of developmental regression and oxidative phosphorylation disorder in a 19-month-old girl. Subtle abnormalities in the serum creatine kinase level, aspartate aminotransferase, and serum bicarbonate led us to perform a muscle biopsy, which showed type I myofiber atrophy, increased lipid content, and reduced cytochrome c oxidase activity. There were marked reductions in enzymatic activities for complex I and III. Complex IV (cytochrome c oxidase) activity was near the 5% confidence level. To determine the frequency of routine laboratory abnormalities in similar patients, we performed a retrospective study including 159 patients with autism (Diagnostic and Statistical Manual of Mental Disorders-IV and Childhood Autism Rating Scale) not previously diagnosed with metabolic disorders and 94 age-matched controls with other neurologic disorders. Aspartate aminotransferase was elevated in 38% of patients with autism compared with 15% of controls (P < .0001). The serum creatine kinase level also was abnormally elevated in 22 (47%) of 47 patients with autism. These data suggest that further metabolic evaluation is indicated in autistic patients and that defects of oxidative phosphorylation might be prevalent. (J Child Neurol 2006;21:170—172; DOI 10.2310/7010.2006.00032).

Get full access to this article

View all access options for this article.

References

Fillano JJ , Goldenthal MJ , Rhodes CH , et al: Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol 2002;17:435—439.

Graf WD , Marin-Garcia J. , Gao HG , et al: Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation . J Child Neurol 2000;15:357—361.

Filipek PA , Juranek J. , Smith M. , et al: Mitochondrial dysfunction in autistic patients with 15q inverted duplication . Ann Neurol 2003;53:801—804

Pons R. , Andrea AL , Checcarelli N. , et al: Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr 2004;144:81—85.

Cornford ME , Philippart M. , Jacobs B. , et al: Neuropathology of Rett syndrome: Case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol 1994;9:424—431.

Heilstedt HA , Shahbazian MD , Lee B. : Infantile hypotonia as a presentation of Rett syndrome. Am J Med Genet 2002;111:238—242.

Wallace DC , Zheng X. , Lott MT , et al: Familial mitochondrial encephalomyopathy (MERRF)—Genetic, pathophysiological and bio-chemical evidence for a mitochondrial DNA mutation . Cell 1998;55:601—610.

Zheng X. , Shoffner JM , Valjavec AS , et al: Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochim Biophys Acta 1990;1019:1—10.

Shoffner JM : Oxidative phosrphorylation diseases, in Scriver CR , Beaudet AL , Sly WS , Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 2001, 2367—2423.

10.

Rogers SJ : Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev 2004;10:139—143.

11.

Lerman-Sagie T. , Leshinsky-Silver E. , Waterberg N. , et al: Should autistic children be evaluated for mitochondrial disorders? J Child Neurol 2004;19:379—381.